| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
53,543,000 |
| Market
Cap: |
11.16(B) |
| Last
Volume: |
762,316 |
Avg
Vol: |
474,459 |
| 52
Week Range: |
$164.52 - $273.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 456 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
| Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
5 |
| Total Shares Sold |
6,002 |
31,084 |
49,996 |
92,833 |
| Total Sell Value |
$1,524,396 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
| Total People Sold |
3 |
6 |
6 |
8 |
| Total Sell Transactions |
5 |
11 |
16 |
28 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
• • – |
2021-06-03 |
4 |
S |
$329.76 |
$263,809 |
D/D |
(800) |
4,230 |
|
-23% |
|
| Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
• • – |
2021-06-03 |
4 |
OE |
$90.43 |
$81,175 |
D/D |
800 |
5,030 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2021-06-01 |
4 |
AS |
$329.18 |
$3,181,749 |
D/D |
(9,577) |
214,799 |
|
25% |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2021-06-01 |
4 |
OE |
$179.66 |
$1,720,604 |
D/D |
9,577 |
224,376 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2021-05-29 |
4 |
D |
$337.99 |
$430,261 |
D/D |
(1,273) |
214,799 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2021-05-29 |
4 |
D |
$337.99 |
$67,936 |
D/D |
(201) |
4,623 |
|
- |
|
| Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
• • – |
2021-05-29 |
4 |
D |
$337.99 |
$18,251 |
D/D |
(54) |
4,230 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2021-05-29 |
4 |
D |
$337.99 |
$73,006 |
D/D |
(216) |
30,027 |
|
- |
|
| Creamer Victoria L |
EVP & Chief People Officer |
• • – |
2021-05-29 |
4 |
D |
$337.99 |
$42,925 |
D/D |
(127) |
6,386 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2021-05-29 |
4 |
D |
$337.99 |
$75,372 |
D/D |
(223) |
12,162 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2021-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,313 |
16,175 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2021-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,006 |
4,824 |
|
- |
|
| Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
• • – |
2021-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
325 |
4,284 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2021-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,183 |
30,243 |
|
- |
|
| Creamer Victoria L |
EVP & Chief People Officer |
• • – |
2021-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,006 |
6,513 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2021-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,124 |
12,385 |
|
- |
|
| Massaro George |
Director |
• • – |
2021-05-11 |
4 |
AS |
$316.75 |
$118,743 |
D/D |
(371) |
5,355 |
|
35% |
|
| Wilson Virginia M |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
355 |
2,167 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2021-05-07 |
4 |
S |
$341.80 |
$2,573,770 |
D/D |
(7,500) |
216,072 |
|
-28% |
|
| Kochevar Deborah Turner |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
355 |
7,083 |
|
- |
|
| Milne George M Jr |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
662 |
29,079 |
|
- |
|
| Mackay Martin |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
574 |
9,599 |
|
- |
|
| Wallman Richard F |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
574 |
32,289 |
|
- |
|
| Bertolini Robert J |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
603 |
29,737 |
|
- |
|
| Reese C Richard |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
589 |
63,478 |
|
- |
|
2062 Records found
|
|
Page 13 of 83 |
|
|
1.28 (0.61%) 
